Cargando…

Reprogramming immunosuppressive myeloid cells by activated T cells promotes the response to anti-PD-1 therapy in colorectal cancer

Overcoming local immunosuppression is critical for immunotherapy to produce robust anti-tumor responses. Myeloid-derived suppressor cells (MDSCs) are key regulators of immunosuppressive networks and promote tumor progression. However, it remains unclear whether and how tumor-infiltrating MDSCs are s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Jing, Sun, Hong-Wei, Yang, Yan-Yan, Chen, Hai-Tian, Yu, Xing-Juan, Wu, Wen-Chao, Xu, Yi-Tuo, Jin, Li-Lian, Wu, Xiao-Jun, Xu, Jing, Zheng, Limin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7791142/ https://www.ncbi.nlm.nih.gov/pubmed/33414378 http://dx.doi.org/10.1038/s41392-020-00377-3

Ejemplares similares

Reprogramming immunosuppressive myeloid cells facilitates immunotherapy for colorectal cancer
por: Lu, Weiqiang, et al.
Publicado: (2020)

Myeloid cell reprogramming alleviates immunosuppression and promotes clearance of metastatic lesions
por: Raghani, Ravi M., et al.
Publicado: (2022)

C-Reactive Protein Is an Indicator of the Immunosuppressive Microenvironment Fostered by Myeloid Cells in Hepatocellular Carcinoma
por: Wang, Yongchun, et al.
Publicado: (2022)

Corrigendum: C-reactive protein is an indicator of the immunosuppressive microenvironment fostered by myeloid cells in hepatocellular carcinoma
por: Wang, Yongchun, et al.
Publicado: (2023)

The Role of Myeloid Cells in GBM Immunosuppression
por: Lin, Ya-Jui, et al.
Publicado: (2022)

Metabolic reprogramming of myeloid-derived suppressive cells
por: Du, Hong, et al.
Publicado: (2017)

PD-L1 expression levels on tumor cells affect their immunosuppressive activity
por: Zheng, Yang, et al.
Publicado: (2019)

Myeloid cells are required for PD-1/PD-L1 checkpoint activation and the establishment of an immunosuppressive environment in pancreatic cancer
por: Zhang, Yaqing, et al.
Publicado: (2017)

Identification of early myeloid progenitors as immunosuppressive cells
por: Pu, Shiming, et al.
Publicado: (2016)

Reprogramming the immunosuppressive tumor microenvironment results in successful clearance of tumors resistant to radiation therapy and anti-PD-1/PD-L1
por: Mukherjee, Debayan, et al.
Publicado: (2023)

Lipid Metabolic Pathways Confer the Immunosuppressive Function of Myeloid-Derived Suppressor Cells in Tumor
por: Yan, Dehong, et al.
Publicado: (2019)

Exosomal PD-L1 Contributes to Immunosuppression and is Associated with anti-PD-1 Response
por: Chen, Gang, et al.
Publicado: (2018)

Impaired immunosuppressive role of myeloid-derived suppressor cells in acquired aplastic anemia
por: Dong, Peiyuan, et al.
Publicado: (2022)

STAT5 promotes PD-L1 expression by facilitating histone lactylation to drive immunosuppression in acute myeloid leukemia
por: Huang, Ze-Wei, et al.
Publicado: (2023)

Engineering ROS‐Responsive Bioscaffolds for Disrupting Myeloid Cell‐Driven Immunosuppressive Niche to Enhance PD‐L1 Blockade‐Based Postablative Immunotherapy
por: Li, Shaoyue, et al.
Publicado: (2022)

Metabolic Reprogramming in Mitochondria of Myeloid Cells
por: Zuo, Hao, et al.
Publicado: (2019)

Exosomal PD-L1 functions as an immunosuppressant to promote wound healing
por: Su, Dandan, et al.
Publicado: (2019)

Myeloid-derived suppressor cells: key immunosuppressive regulators and therapeutic targets in hematological malignancies
por: Wang, Shifen, et al.
Publicado: (2023)

Glutamine Deprivation Promotes the Generation and Mobilization of MDSCs by Enhancing Expression of G-CSF and GM-CSF
por: Sun, Hong-Wei, et al.
Publicado: (2021)

Immunopotentiator Aikejia improves the therapeutic efficacy of PD-1/PD-L1 immunosuppressive pathway in CT26.WT cancer cell
por: Huang, Chaoqun, et al.
Publicado: (2019)

A Fc-VEGF chimeric fusion enhances PD-L1 immunotherapy via inducing immune reprogramming and infiltration in the immunosuppressive tumor microenvironment
por: Kuo, Cheng-Liang, et al.
Publicado: (2022)

Glucosamine Interferes With Myelopoiesis and Enhances the Immunosuppressive Activity of Myeloid-Derived Suppressor Cells
por: Lin, Eric Chang-Yi, et al.
Publicado: (2021)

Hypoxia-reprogrammed regulatory group 2 innate lymphoid cells promote immunosuppression in pancreatic cancer
por: Ye, Longyun, et al.
Publicado: (2022)

Immunosuppressive Cell Subsets and Factors in Myeloid Leukemias
por: Swatler, Julian, et al.
Publicado: (2021)

MFSD2A potentiates gastric cancer response to anti‐PD‐1 immunotherapy by reprogramming the tumor microenvironment to activate T cell response
por: Zhang, Bin, et al.
Publicado: (2023)

Identification of Reprogrammed Myeloid Cell Transcriptomes in NSCLC
por: Durrans, Anna, et al.
Publicado: (2015)

PERK reprograms hematopoietic progenitor cells to direct tumor-promoting myelopoiesis in the spleen
por: Liu, Mingyu, et al.
Publicado: (2022)

In Situ Nitric Oxide Gas Nanogenerator Reprograms Glioma Immunosuppressive Microenvironment
por: Liu, Yang, et al.
Publicado: (2023)

Polysaccharide from Lentinus edodes Inhibits the Immunosuppressive Function of Myeloid-Derived Suppressor Cells
por: Wu, Hao, et al.
Publicado: (2012)

Lactate-Lactylation Hands between Metabolic Reprogramming and Immunosuppression
por: Chen, Lihua, et al.
Publicado: (2022)

Immunosuppression by Inflammation-Stimulated Amplification of Myeloid-Derived Suppressor Cells and Changes in Expression of Immune Checkpoint HHLA2 in Chronic Obstructive Pulmonary Disease
por: Xu, Lijuan, et al.
Publicado: (2023)

Mechanisms of Immunosuppression in Colorectal Cancer
por: Zhang, Yang, et al.
Publicado: (2020)

TRAF6 Regulates the Immunosuppressive Effects of Myeloid-Derived Suppressor Cells in Tumor-Bearing Host
por: Song, Ge, et al.
Publicado: (2021)

Immunosuppressive Role of Myeloid-Derived Suppressor Cells and Therapeutic Targeting in Lung Cancer
por: Ma, Jie, et al.
Publicado: (2018)

BRAF(V600E) mutant colorectal cancer cells mediate local immunosuppressive microenvironment through exosomal long noncoding RNAs
por: Zhi, Jie, et al.
Publicado: (2021)

Correction: PERK reprograms hematopoietic progenitor cells to direct tumor-promoting myelopoiesis in the spleen
por: Liu, Mingyu, et al.
Publicado: (2022)

Conditional reprogramming: next generation cell culture
por: Wu, Xiaoxiao, et al.
Publicado: (2020)

Ex vivo generation of myeloid-derived suppressor cells that model the tumor immunosuppressive environment in colorectal cancer
por: Dufait, Inès, et al.
Publicado: (2015)

Rapid intestinal and systemic metabolic reprogramming in an immunosuppressed environment
por: Ma, Bing, et al.
Publicado: (2023)

EZH2 negatively regulates PD-L1 expression in hepatocellular carcinoma
por: Xiao, Gang, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_g3gq8mbdobl7umth8nb3komosr